The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC): CALGB 80802 (Alliance).
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Aduro Biotech (I); Astellas Pharma; AstraZeneca (I); Celgene; Celsion; cipla; Exelixis; IntegraGen; Jennerex; Lilly/ImClone; MedImmune; Novartis; Pharmacyclics (I); Sanofi (I); Silenseed (I); Vicus Therapeutics
Research Funding - Abbott Laboratories (Inst); Amgen (Inst); Bayer (Inst); Exelixis (Inst); Genentech (Inst); Lilly/ImClone (Inst); Novartis (Inst); Polaris (Inst); Roche (Inst); Vicus Therapeutics (Inst)
Travel, Accommodations, Expenses - Polaris
 
Donna Niedzwieski
No Relationships to Disclose
 
Jennifer J. Knox
Honoraria - Novartis
Consulting or Advisory Role - Lilly
Research Funding - AstraZeneca
 
Andreas Kaubisch
No Relationships to Disclose
 
James Posey
Honoraria - Novartis
Research Funding - Genomic Health (Inst)
 
Benjamin R. Tan
Consulting or Advisory Role - Roche/Genentech
Research Funding - Bayer; Eisai; Exelixis; Lilly; Merck Serono; Pfizer; Roche/Genentech; Xcovery
 
Petr Kavan
Honoraria - Celgene; LEO Pharma
Consulting or Advisory Role - Novartis; Pfizer; Roche canada; Sanofi
Travel, Accommodations, Expenses - Amgen; Roche/Genentech; Sanofi
 
Rakesh Goel
No Relationships to Disclose
 
John J. Murray
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly; NCCN; Pfizer; Regeneron; Research to Practice; Sanofi; Sirtex Medical; Taiho Pharmaceutical
Other Relationship - Exelixis; Polaris
 
Vincent Channing Tam
No Relationships to Disclose
 
Lakshmi Rajdev
No Relationships to Disclose
 
Robin Kate Kelley
Consulting or Advisory Role - Acceleron Pharma; Lilly
Research Funding - Celgene (Inst); Exelixis (Inst); Lilly (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Tekmira (Inst)
 
Abby Siegel
Employment - Merck
 
Jennifer Balletti
No Relationships to Disclose
 
James J. Harding
No Relationships to Disclose
 
Lawrence HOWARD Schwartz
Honoraria - Merck KGaA; Pfizer
Patents, Royalties, Other Intellectual Property - Varian Medical Systems
Other Relationship - BioClinica; ICON Clinical Research
 
Richard M. Goldberg
Honoraria - Baxter; Biothera; Immunocare Therapies; kanghong Pharma; Lilly; Momenta Pharmaceuticals; Novo Nordisk; Sanofi
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Baxter; Merck KGaA; Sanofi
 
Monica M. Bertagnolli
No Relationships to Disclose
 
Alan P. Venook
Honoraria - Gilead Sciences
Consulting or Advisory Role - Gilead Sciences
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Onyx (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Halozyme; Merck Serono; Roche